How is the Keros Therapeutics Inc today?

The Keros Therapeutics Inc today is trading in the down by -0.87% at 14.82.

How has Keros Therapeutics Inc performed historically?

The Keros Therapeutics Inc is currently trading down -0.87% on an intraday basis in the past week the index rose 3.28%. The index has been up 33.51% in the past quarter and fell -69.55% in the past year. You can view this in the overview section.

What is Keros Therapeutics Inc Annual Revenue?

Keros Therapeutics Inc Annual Revenue rose 2,250.99%, in the last year to $3.55 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Keros Therapeutics Inc Annual Net Profit?

Keros Therapeutics Inc Annual Net Profit fell 22.46% in the last year to $187.35 M. Its sector's average net profit growth for the last fiscal year was -13.86%.

What is Keros Therapeutics Inc Price to Earning Ratio?

Keros Therapeutics Inc Price to Earning Ratio is 142.91, higher than its sector PE ratio of 4.55.

What is Keros Therapeutics Inc Stock Price?

Keros Therapeutics Inc Stock Price fell 69.55% and underperformed its sector by 97.99% in the past year.

What is Keros Therapeutics Inc Quarterly Revenue?

Keros Therapeutics Inc Quarterly Revenue rose 254,413.25% YoY to $211.25 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Keros Therapeutics Inc Quarterly Net profit?

Keros Therapeutics Inc Quarterly Net profit rose 444.32% YoY to $148.45 M. Its sector's average net profit growth YoY for the quarter was -238.4%.

What is Keros Therapeutics Inc Debt to Equity Ratio?

Keros Therapeutics Inc Debt to Equity Ratio of 0.03 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Keros Therapeutics Inc Return on Equity(ROE)?

Keros Therapeutics Inc Return on Equity(ROE) for the last financial year was -41.46%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Keros Therapeutics Inc Mutual Fund Holding?

Keros Therapeutics Inc Mutual Fund Holding increased by 5.23% in the last quarter to 36.69.

What is Keros Therapeutics Inc Institutional Holding?

Keros Therapeutics Inc Institutional Holding decreased by 4.85% in the last quarter to 85.58.

Keros Therapeutics Inc XNAS: KROS

Keros Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Keros Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Keros Therapeutics Inc
Rating: 1.940694375
Author: Trendlyne DVM scores

Expensive Performer

about

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet m...

14.82 -0.13 (-0.87%)

79.52% Fall from 52W High

455.9K XNAS Volume

XNAS 04 Jun, 2025 5:30 PM (EDT)

Board Meeting

The latest board meeting for Keros Therapeutics Inc took place on 04 Jun 2025, for the purpose of Keros Therapeutics Inc Annual General Meeting for 2025 See details

Medium Financial Strength

44.4 / 100

Expensive Valuation

28.2 / 100

Technically Neutral

38.2 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 106%

10 analysts

Keros Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Keros Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet m...

79.52% Fall from 52W High

SWOT Analysis

Keros Therapeutics Inc Live Price Chart

Keros Therapeutics Inc FAQ

How is Keros Therapeutics Inc today?

Keros Therapeutics Inc today is trading in the red, and is down by -0.87% at 14.82.

How has Keros Therapeutics Inc performed historically?

Keros Therapeutics Inc is currently trading down -0.87% on an intraday basis. In the past week the stock rose 3.28%. stock has been up 33.51% in the past quarter and fell -69.55% in the past year. You can view this in the overview section.